Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, Aug 1995, 1878-1880, Vol 39, No. 8
SB Vakulenko, M Toth, P Taibi, S Mobashery and SA Lerner
To examine the effect of disruption of the salt bridge (between Arg-164 and
Asp-179 [numbering of Ambler et al. (Biochem J. 267:269-272, 1991)]) that
anchors the conserved omega-loop in class A beta- lactamases, we obtained
mutant enzymes with each of the 19 other amino acid residues replacing
Asp-179 in the TEM beta-lactamase encoded by pUC19 and studied the level of
resistance to various beta-lactams conferred by each enzyme. All mutations
of Asp-179 compromised the level of resistance to ampicillin, but most of
them enhanced resistance to ceftazidime. In contrast, mutations of Asp-179
generally impaired the low levels of resistance to cefepime and aztreonam.
One might expect to find clinical isolates with mutant TEM beta-lactamases
with replacements of Asp-179 that express an expanded spectrum of
resistance to beta-lactams including ceftazidime.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Effects of Asp-179 mutations in TEMpUC19 beta-lactamase on susceptibility to beta-lactams
Department of Medicine, Wayne State University, Detroit, Michigan 48202, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»